Cite
Mauri MC, Turner M, Volonteri LS, et al. Dosing patterns in Europe: Efficacy and safety of risperidone long-acting injectable in doses of 25, 37.5 and 50 mg. Int J Psychiatry Clin Pract. 2009;13(1):36-47doi: 10.1080/13651500802411979.
Mauri, M. C., Turner, M., Volonteri, L. S., Medori, R., & Maier, W. (2009). Dosing patterns in Europe: Efficacy and safety of risperidone long-acting injectable in doses of 25, 37.5 and 50 mg. International journal of psychiatry in clinical practice, 13(1), 36-47. https://doi.org/10.1080/13651500802411979
Mauri, Massimo Carlo, et al. "Dosing patterns in Europe: Efficacy and safety of risperidone long-acting injectable in doses of 25, 37.5 and 50 mg." International journal of psychiatry in clinical practice vol. 13,1 (2009): 36-47. doi: https://doi.org/10.1080/13651500802411979
Mauri MC, Turner M, Volonteri LS, Medori R, Maier W. Dosing patterns in Europe: Efficacy and safety of risperidone long-acting injectable in doses of 25, 37.5 and 50 mg. Int J Psychiatry Clin Pract. 2009;13(1):36-47. doi: 10.1080/13651500802411979. PMID: 24946121.
Copy
Download .nbib